Jeffrey Shuren was the Director of the Center for Devices and Radiological Health (CDRH) at the United States Food and Drug Administration (FDA) from September 2009 to July 2024.[1][2]
Shuren was responsible for the development of Medicare national coverage determinations for drugs, biologics, and non-implantable devices, while director of the Division of Items and Devices, Coverage and Analysis Group at the Centers for Medicare and Medicaid Services.[1] His long-term position as director of CDRH was one of tremendous responsibility and importance; according to the New York Times, "Dr. Shuren led an office with about 2,500 staff members and a budget of about $790 million. He oversaw thousands of devices, ranging from tests to detect blood-lead levels to IV infusion pumps to ventilators."[2]
Jeffrey Shuren announced his plans to retire from the agency in July 2024.[2]
FDA
was invoked but never defined (see the help page).